Evidence map›Paper›PMID 21908599›Full record

ArticleEukaryotic cell2011

Curcumin inhibits growth of Saccharomyces cerevisiae through iron chelation.

Steven Minear, Allyson F O'Donnell, Anna Ballew, Guri Giaever, Corey Nislow, Tim Stearns, Martha S Cyert

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2017
    Article
  14. Article
  15. Article
  16. Degradation of Curcumin: From Mechanism to Biological Implications.Journal of agricultural and food chemistry · 2015
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Steven MinearDepartment of Biology, Stanford University, Stanford, CA 94305-5020, USA.
Allyson F O'Donnell
Anna Ballew
Guri Giaever
Corey Nislow
Tim Stearns
Martha S Cyert
Stanford University · US

Funding

GAMMA TUBULIN AND CENTROSOME STRUCTURE AND FUNCTIONR01GM052022 · NIGMS · STANFORD UNIVERSITY · PI STEARNS, TIM · 1995 to 2017
$6.5M
CIHR 81340CIHR 84305NIGMS NIH HHS GM-48728NIGMS NIH HHS GM52022NIGMS NIH HHS R01 GM052022
6 · The paper itself

Abstract

Curcumin, a polyphenol derived from turmeric, is an ancient therapeutic used in India for centuries to treat a wide array of ailments. Interest in curcumin has increased recently, with ongoing clinical trials exploring curcumin as an anticancer therapy and as a protectant against neurodegenerative diseases. In vitro, curcumin chelates metal ions. However, although diverse physiological effects have been documented for this compound, curcumin's mechanism of action on mammalian cells remains unclear. This study uses yeast as a model eukaryotic system to dissect the biological activity of curcumin. We found that yeast mutants lacking genes required for iron and copper homeostasis are hypersensitive to curcumin and that iron supplementation rescues this sensitivity. Curcumin penetrates yeast cells, concentrates in the endoplasmic reticulum (ER) membranes, and reduces the intracellular iron pool. Curcumin-treated, iron-starved cultures are enriched in unbudded cells, suggesting that the G(1) phase of the cell cycle is lengthened. A delay in cell cycle progression could, in part, explain the antitumorigenic properties associated with curcumin. We also demonstrate that curcumin causes a growth lag in cultured human cells that is remediated by the addition of exogenous iron. These findings suggest that curcumin-induced iron starvation is conserved from yeast to humans and underlies curcumin's medicinal properties.

Indexed as

Biological TransportCell CycleCell Cycle CheckpointsCell Line, TumorCell MembraneCopperCurcuminEndoplasmic ReticulumHumansIronIron Chelating AgentsMutationSaccharomyces cerevisiaeCopperCurcuminIronIron Chelating Agents

Identifiers

PMID21908599
PMCPMC3209049
OpenAlexW2124513795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.